Left ventricular function in rheumatoid arthritis during anti-TNF-α treatment: a speckle tracking prospective echocardiographic study

Submitted: March 21, 2016
Accepted: May 9, 2016
Published: June 22, 2016
Abstract Views: 1713
PDF: 864
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.


Aim. Rheumatoid arthritis (RA) shows a high risk for cardiovascular disease, including heart failure. Although TNF-α has been implicated in the pathogenesis of myocardial remodelling, TNF-α inhibition did not show any efficacy in patients with advanced heart failure and should be contraindicated in RA with cardiac complications. We aimed to assess global left ventricular (LV) systolic function using global longitudinal strain (GLS) as a measure of myocardial deformation, in a group of RA patients before and during anti-TNF-α treatment. Methods. 13 patients (female:male 7:6) affected by RA were prospectively followed for one year during anti TNF-α treatment. Every subject underwent echocardiography before starting anti-TNF-α drugs and after one year of treatment, to evaluate LV ejection fraction (EF), telediastolic diameter, telediastolic volume and global longitudinal strain (GLS) that was calculated using 2D speckle tracking as the mean GLS from three standard apical views (2, 3 and 4 -chambers). The patients showed a mean age of 43 years at RA onset (SD: 13) and a mean follow-up of 7.3 years (SD: 4.8). Steroid and methotrexate were used in 84.6% and 100%, respectively, in association with etanercept (6 cases), adalimumab (4 cases) and infliximab (3 cases). Results. Patients globally showed a normal EF before and after one year of treatment (mean: 65% and 65.7%, respectively). GLS did not differ before or after anti-TNF-α treatment (mean: -15.8% and -16.7%, respectively). Conclusion. Anti-TNF-α treatment did not significantly modify myocardial contractility after 12 months.





PlumX Metrics


Download data is not yet available.


How to Cite

Vizzardi, Enrico, Ilaria Cavazzana, Franco Franceschini, Ivano Bonadei, Edoardo Sciatti, Carlo M Lombardi, Angela Tincani, and Marco Metra. 2016. “Left Ventricular Function in Rheumatoid Arthritis During Anti-TNF-α Treatment: A Speckle Tracking Prospective Echocardiographic Study”. Monaldi Archives for Chest Disease 84 (1-2). https://doi.org/10.4081/monaldi.2015.716.